RP-6557

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameRP-6557
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionPhosphatidylinositol 3 kinase alpha modulatorsPhosphatidylinositol 3 kinase delta modulators
TargetsPhosphatidylinositol 3 kinase alphaPhosphatidylinositol 3 kinase delta
Therapy Area/IndicationsIdiopathic Pulmonary FibrosisPulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesRhizen Pharmaceuticals Sa
China Registration ClassN/A

Develop Information

Active CompaniesRhizen Pharmaceuticals Sa
Inactive CompaniesN/A
Active IndicationsIdiopathic Pulmonary FibrosisPulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A